Annual accounts
Total Exemption Full accounts
30/09/2027Filing deadline
- Next accounts made up to
- 31/12/2026
- Last accounts made up to
- 30/06/2025
Reference data exactly as held at Companies House.
The 4 most recent documents filed at Companies House.
Current accounting period extended from 2026-06-30 to 2026-12-31
Memorandum and Articles of Association
Resolutions
Appointment of Mr Nathan Pettitt as a director on 2026-03-12
What Pre-Score will tell you

The two filings Companies House requires every year, and where each one stands against its deadline today.
Total Exemption Full accounts
30/09/2027Filing deadline
Confirms the registry record is up to date
24/02/2027Filing deadline
The latest figures BIOSPECTRUM LIMITED filed. Okredo holds filed accounts data for 2021–2025; the year-by-year record is on the financials page.
Net Assets
2024: £677.03K
Total Assets
2024: £1.22M
Cash in Bank
2024: £87.79K
Total Liabilities
2024: £538.96K
Employees
2024: 8
Of the 4 measures with an earlier filing to compare against, 4 rose. Total assets moved furthest, up 57.00% on 2024. See the full financial analysis for BIOSPECTRUM LIMITED.
The full financial record
Four ways through BIOSPECTRUM LIMITED's filed accounts — the year-by-year numbers, the compound rates and the ratios behind them.
Headcount as reported to Companies House for 2021–2025.
| Year | Employees | Change |
|---|---|---|
| 2025 | 14 | +6 |
| 2024 | 8 | +2 |
| 2023 | 6 | 0 |
| 2022 | 6 | -2 |
| 2021 | 8 | – |
Reported employee count increased from 8 in 2021 to 14 in 2025. See how headcount moved alongside the reported financials.
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
Directors, secretaries and other appointed officers, with the period each has served.
| Person | Role | Period | Connected companies |
|---|---|---|---|
| Director | 12/03/2026–Present | 14 | |
| Director | 02/10/2023–12/03/2026 | 1 | |
| Director | 24/11/2017–Present | 3 | |
| Director | 02/11/2023–12/03/2026 | 0 | |
| Director | 24/11/2017–17/09/2018 | 0 | |
| Director | 24/11/2017–17/09/2018 | 0 | |
| Secretary | 17/09/2018–Present | 0 | |
| Director | 02/11/2023–Present | 1 | |
| Director | 27/06/2018–Present | 7 | |
| Director | 02/11/2023–12/03/2026 | 0 | |
| Secretary | 01/06/2018–17/09/2018 | 0 | |
| Director | 12/03/2026–Present | 3 | |
| Director | 12/03/2026–Present | 1 | |
| Director | 16/04/2021–12/03/2026 | 1 |
Individuals or entities with significant control over the company, as declared to Companies House.
| Person | Period | Connected companies |
|---|---|---|
| 24/11/2017–26/02/2026 | 3 | |
| 12/03/2026–Present | 4 | |
| 24/11/2017–Present | 3 |
Every document on the Companies House record, newest first.
Current accounting period extended from 2026-06-30 to 2026-12-31
Memorandum and Articles of Association
Resolutions
Appointment of Mr Nathan Pettitt as a director on 2026-03-12
Appointment of Mr Stephen Mark Arundel as a director on 2026-03-12
Appointment of Tom Nichlas Essner as a director on 2026-03-12
Termination of appointment of Mary Frances Mcquilkin as a director on 2026-03-12
Termination of appointment of Mohamad Wasim Mahmalji as a director on 2026-03-12
Termination of appointment of Charles Mcquilkin as a director on 2026-03-12
Termination of appointment of Brett Lamper as a director on 2026-03-12
Notification of Addlife Ab as a person with significant control on 2026-03-12
Cessation of Penelope Ann Mcquilkin as a person with significant control on 2026-02-26
Showing 12 of 68 filings
See when the next accounts and confirmation statement are due
351 UK companies are similar to BIOSPECTRUM LIMITED, sharing the same company status (Active), the same industry sector and activity group (Hospital activities) and a comparable number of employees. The 5 closest matches are shown below to help you compare competitors and industry peers.
Lake House 2 Port Way, Port Solent, Portsmouth, Hampshire PO6 4TY
15 Basset Court Loake Close, Grange Park, Northampton NN4 5EZ
146 New London Road, Chelmsford, Essex CM2 0AW
86 Crown Street, Aberdeen AB11 6ET
Lister House Lister Hill, Horsforth, Leeds LS18 5AZ
A short description of the company, written from its Companies House record.
BIOSPECTRUM LIMITED is a private limited company registered in the United Kingdom, based in Unit 9 Halifax Court, Fernwood Business Park, Newark, Nottinghamshire NG24 3JP. Companies House classifies its business as Hospital activities, one of 2 SIC classifications on its record. It has been on the register for 8 years 10 months.
The register currently records it as active. Its 2025 accounts report net assets of £1.18M and 14 employees.
Answered from this company's own registry record and filed figures.
Companies House records BIOSPECTRUM LIMITED under 2 registered business activities: Hospital activities (86.10/1 - SIC 2007) and General medical practice activities (86.21 - SIC 2007).
BIOSPECTRUM LIMITED is recorded as active on the Companies House register, and has been on it since 24/11/2017.
The most recent accounts Okredo holds cover 2025 and report net assets of £1.18M, total assets of £1.91M, cash in bank of £176.87K and total liabilities of £729.50K.
The most recent document on the record is dated 18/06/2026: Current accounting period extended from 2026-06-30 to 2026-12-31, 3 months ago.
On the current registry record, accounts are due by 30/09/2027 and the next confirmation statement is due by 24/02/2027.
Companies House lists 14 officers (7 currently in post) and 3 people with significant control (2 current).